Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Campora

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study GroupM A Dicato, S Kaasa, E Campora, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1991
Tamoxifen and alpha interferon in advanced breast cancerL Miglietta, L Repetto, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancerL Repetto, L Miglietta, G Gardin, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Breast Cancer Research and Treatment|January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancerG Gardin, A Alama, R Rosso, et al.
Anticancer Research|July 1, 1987
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administrationE Campora, M Esposito, D Civalleri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The impact of received dose intensity on the outcome of advanced ovarian cancerL Repetto, M Pace, S Mammoliti, et al.
Breast Cancer Research and Treatment|March 1, 1997
A retrospective comparison of detection and treatment of breast cancer in young and elderly patientsL Repetto, M Costantini, E Campora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized cooperative study of perioperative chemotherapy in breast cancerM R Sertoli, P Bruzzi, P Pronzato, et al.
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study GroupM A Dicato, S Kaasa, E Campora, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1991
Tamoxifen and alpha interferon in advanced breast cancerL Miglietta, L Repetto, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancerL Repetto, L Miglietta, G Gardin, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Breast Cancer Research and Treatment|January 1, 1994
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancerG Gardin, A Alama, R Rosso, et al.
Anticancer Research|July 1, 1987
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administrationE Campora, M Esposito, D Civalleri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The impact of received dose intensity on the outcome of advanced ovarian cancerL Repetto, M Pace, S Mammoliti, et al.
Breast Cancer Research and Treatment|March 1, 1997
A retrospective comparison of detection and treatment of breast cancer in young and elderly patientsL Repetto, M Costantini, E Campora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized cooperative study of perioperative chemotherapy in breast cancerM R Sertoli, P Bruzzi, P Pronzato, et al.
Anticancer Research|September 1, 1992
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMFE Campora, P Pronzato, D Amoroso, et al.
Pageof 8